Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis

Bibliographic Details
Main Authors: Annalisa Capuano, Emilio Clementi, Giuseppe Paolisso
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1040649/full
_version_ 1828126384200876032
author Annalisa Capuano
Emilio Clementi
Giuseppe Paolisso
Giuseppe Paolisso
author_facet Annalisa Capuano
Emilio Clementi
Giuseppe Paolisso
Giuseppe Paolisso
author_sort Annalisa Capuano
collection DOAJ
first_indexed 2024-04-11T15:34:30Z
format Article
id doaj.art-54b87655e74d4482acb7952fdb4ab1f2
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T15:34:30Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-54b87655e74d4482acb7952fdb4ab1f22022-12-22T04:16:03ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10406491040649Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosisAnnalisa Capuano0Emilio Clementi1Giuseppe Paolisso2Giuseppe Paolisso3Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, ItalyDepartment of Biomedical and Clinical Sciences, University of Milan, Milan, ItalyDepartment of Advanced Medical and Clinical Science, University of Campania “Luigi Vanvitelli”, Naples, ItalyMediterranea Cardiocentro, Naples, Italyhttps://www.frontiersin.org/articles/10.3389/fcvm.2022.1040649/fullatherosclerosisSGLT2 inhibitorscardiovascular diseasesacute myocardial infarctionheart failureperipheral artery diseases
spellingShingle Annalisa Capuano
Emilio Clementi
Giuseppe Paolisso
Giuseppe Paolisso
Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
Frontiers in Cardiovascular Medicine
atherosclerosis
SGLT2 inhibitors
cardiovascular diseases
acute myocardial infarction
heart failure
peripheral artery diseases
title Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
title_full Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
title_fullStr Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
title_full_unstemmed Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
title_short Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
title_sort editorial clinical prospective of sglt2 inhibitors in atherosclerosis
topic atherosclerosis
SGLT2 inhibitors
cardiovascular diseases
acute myocardial infarction
heart failure
peripheral artery diseases
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1040649/full
work_keys_str_mv AT annalisacapuano editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis
AT emilioclementi editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis
AT giuseppepaolisso editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis
AT giuseppepaolisso editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis